tiprankstipranks
Advertisement
Advertisement

HAE Stock Latest News

Citi adds ‘downside 90-day catalyst watch’ on Haemonetics
The FlyCiti adds ‘downside 90-day catalyst watch’ on Haemonetics
6d ago
HAE
Haemonetics management to meet virtually with BTIG
PremiumThe Fly
Haemonetics management to meet virtually with BTIG
27d ago
HAE
Haemonetics price target raised to $85 from $70 at Mizuho
PremiumThe Fly
Haemonetics price target raised to $85 from $70 at Mizuho
28d ago
HAE
Haemonetics: Buy Rating Reiterated as New Apheresis Reporting Boosts Transparency; $80 Price Target Maintained
PremiumRatings
Haemonetics: Buy Rating Reiterated as New Apheresis Reporting Boosts Transparency; $80 Price Target Maintained
1M ago
HAE
Haemonetics Unveils New Two-Segment Financial Reporting Structure
PremiumCompany Announcements
Haemonetics Unveils New Two-Segment Financial Reporting Structure
1M ago
8K
HAE
Haemonetics price target raised to $70 from $64 at Citi
PremiumThe FlyHaemonetics price target raised to $70 from $64 at Citi
2M ago
HAE
Haemonetics upgraded to Buy at BofA on upside to guidance
Premium
The Fly
Haemonetics upgraded to Buy at BofA on upside to guidance
2M ago
HAE
Haemonetics upgraded to Buy from Neutral at BofA
Premium
The Fly
Haemonetics upgraded to Buy from Neutral at BofA
2M ago
HAE
Haemonetics’ Global ERP Rollout Poses Execution Risks, Potential Margin Pressure and Operational Disruption
PremiumCompany Announcements
Haemonetics’ Global ERP Rollout Poses Execution Risks, Potential Margin Pressure and Operational Disruption
2M ago
HAE
Haemonetics price target lowered to $89 from $94 at Barrington
PremiumThe Fly
Haemonetics price target lowered to $89 from $94 at Barrington
2M ago
HAE
Haemonetics Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
Haemonetics Earnings Call Highlights Growth Amid Headwinds
2M ago
HAE
Haemonetics price target lowered to $67 from $72 at Baird
PremiumThe Fly
Haemonetics price target lowered to $67 from $72 at Baird
2M ago
HAE
Haemonetics price target lowered to $62 from $74 at JPMorgan
PremiumThe FlyHaemonetics price target lowered to $62 from $74 at JPMorgan
2M ago
HAE
Haemonetics reports Q4 adjusted EPS $1.29, consensus $1.27
Premium
The Fly
Haemonetics reports Q4 adjusted EPS $1.29, consensus $1.27
2M ago
HAE
Haemonetics sees FY27 adjusted EPS up 4%-7%
Premium
The Fly
Haemonetics sees FY27 adjusted EPS up 4%-7%
2M ago
HAE
Haemonetics (HAE) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Haemonetics (HAE) Q4 Earnings Cheat Sheet
2M ago
HAE
Haemonetics Announces Upcoming Departure of Longtime Board Director
PremiumCompany Announcements
Haemonetics Announces Upcoming Departure of Longtime Board Director
2M ago
8K
HAE
Haemonetics price target lowered to $70 from $80 at Mizuho
PremiumThe Fly
Haemonetics price target lowered to $70 from $80 at Mizuho
3M ago
HAE
Haemonetics price target lowered to $84 from $88 at BTIG
PremiumThe Fly
Haemonetics price target lowered to $84 from $88 at BTIG
3M ago
HAE
Haemonetics price target lowered to $64 from $70 at Citi
PremiumThe FlyHaemonetics price target lowered to $64 from $70 at Citi
3M ago
HAE
Haemonetics: FDA Label Expansion and New Product Launches Poised to Reignite Vascular Closure Growth by FY27
Premium
Ratings
Haemonetics: FDA Label Expansion and New Product Launches Poised to Reignite Vascular Closure Growth by FY27
3M ago
HAE
Haemonetics: FDA approves expanded labeling for VASCADE MVP XL system
Premium
The Fly
Haemonetics: FDA approves expanded labeling for VASCADE MVP XL system
4M ago
HAE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >